# Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder

> **NCT01355081** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 366 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Vortioxetine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01355081
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 366 (ACTUAL)
- **Last updated:** 2014-11-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01355081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01355081, "Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01355081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*